The two plan to combine their respective databases of health insurance claims and clinical records in order to evaluate health procedures and find ways to improve them.
Health Care + Med Tech
The “Breakthrough Health Challenge” seeks ideas about how common consumer technologies or devices can be used in new ways to help people address chronic conditions like diabetes, heart disease, and obesity.
The medical device giant said it would make improvements to its processes and address specific concerns raised during an inspection of its Sylmar, California facility.
Minnesota health care companies attracted $164.7 million in 2012, down 26.2 percent from 2011; still, the state received the second-highest funding amount among the region’s 11 states.
No money changed hands in connection with the merger, and no layoffs are expected; the joint organization will operate under the HealthPartners name.
The health care insurer, which pushed out its former chief executive in July, has appointed Michael Guyette as its next leader.
According to a new report from the United Health Foundation, the state’s sedentary lifestyle and diabetes rates are among the lowest in the nation, but the figures are still concerning.
The two senators reportedly believe that the 2.3 percent tax on medical device sales will hurt companies’ profits and lead to job losses in the country.
Allina’s CIO talks about how technology is improving the patient experience.
The Minnetonka-based health insurer said that it expects to earn $5.25 to $5.50 per share in 2013, less than the $5.58 per share that analysts have predicted.
Dorsey & Whitney Managing Partner Marianne Short is leaving the firm at the end of this year to join UnitedHealth Group as chief legal officer.
The company said that its 26 percent drop in quarterly profits was due to $245 million in litigation expenses and the impact of foreign currency rates.
Imris, Inc., will relocate about 60 employees from its current home office in Winnipeg and hire local residents for an additional 70 positions.
As part of a reorganization plan that the company expects will help cut costs, St. Jude will reduce its global work force by approximately 5 percent—in addition to the 300 jobs it eliminated in August.
Can a campaign that shows
employees thanking bosses for their insurance plan be believed?
A U.S. Senate Finance Committee report based on thousands of documents from Medtronic adds to the controversy surrounding the company’s bone-growth product Infuse, but Medtronic said that it “vigorously disagrees” with the committee’s claims.
The medical device giant said that the letter contained “11 observations” about its manufacturing plant in Sylmar, California; St. Jude vowed to respond to the FDA by November 7 and said it “has initiated efforts and redirected resources to address the FDA’s observations.”
DiaMedica, which is developing drugs to treat diabetes, chose to move to the Twin Cities because of the area's strong life sciences sector, among other benefits.